Brian O'Callaghan

Brian O'Callaghan was the founder of Biopartners GmbH, founded in 2000, where the title held was President & Chief Executive Officer from 2000 to 2004.
Current jobs include Chief Executive Officer & Director at Deep Genomics, Inc. since 2023; Independent Chairman at Bolt Biotherapeutics, Inc. since 2024; Director at Century Club of San Diego; and Director at Petra Pharma Corp.
since 2020.
Former jobs include President, Chief Executive Officer & Director at Sangart, Inc. from 2008 to 2014; President, Chief Executive Officer & Director at Acucela, Inc. in 2015; Chief Executive Officer at Sonrgy, Inc. from 2015 to 2017; Director at Aquavit Pharmaceuticals, Inc.; Director at Intec Pharma Ltd.; Director at ObsEva SA in 2023; Director at Decoy Biosystems, Inc.; Independent Director at Indaptus Therapeutics, Inc.; Director at Biocom, Inc.; Chief Commercial Officer at NPS Pharmaceuticals, Inc. from 2007 to 2008; General Manager at Labcorp Drug Development, Inc.; General Manager at Merck KGaA; GM-North American Transplantation & Immunology at Novartis Pharmaceuticals Corp.
from 2004 to 2006; and Chief Executive & Financial Officer at Kubota Pharmaceutical Holdings Co., Ltd. Education includes an MBA from Henley Business School Ltd.